The S&P 500® Index is an unmanaged index of common stock performance. You cannot invest directly in an index.Consider these risks before investing: Biology revolution companies face intense competition and potentially rapid product obsolescence. Biology revolution companies may be adversely affected by the loss or impairment of intellectual property rights and other proprietary information or changes in government regulations. The potential for an increased amount of required disclosure or lack of access to proprietary scientific information could negatively impact the performance of these companies. Investments in small and/or midsize companies increase the risk of greater price fluctuations. Growth stocks may be more susceptible to earnings disappointments, and value stocks may fail to rebound. The value of investments in the fund's portfolio may fall or fail to rise over extended periods of time for a variety of reasons, including general economic, political, or financial market conditions; investor sentiment and market perceptions; government actions; geopolitical events or changes; and factors related to a specific issuer, geography, industry, or sector. These and other factors may lead to increased volatility and reduced liquidity in the fund's portfolio holdings. As a non-diversified fund, the fund invests in fewer issuers and is more vulnerable than a more broadly diversified fund to fluctuations in the values of the securities it holds. Our investment techniques, analyses, and judgments may not produce the outcome we intend. The investments we select for the fund may not perform as well as other securities that we do not select for the fund. We, or the fund's other service providers, may experience disruptions or operating errors that could have a negative effect on the fund. You can lose money by investing in the fund.
Putnam BioRevolution ETF (Class A) (SYNB)
Investing in companies that are leveraging innovation within biology
Harnessing the biorevolution for investors
The revolution in biology and life sciences is unleashing new potential for innovation across many sectors, creating opportunities for investors.Read more
NAV as of 12/06/22
Market data all data below as of 12/06/22
|Closing market price||$26.52|
|30-day median bid-ask spread||0.19%|
|30-day average trading volume||125|
|Net assets and outstanding shares||Download CSV|
How to buy Putnam ETFs
Putnam ETFs can be purchased and sold the same way you would buy or sell a stock — through most self-directed brokers or with the guidance of your advisor. Opening an online, self-directed brokerage account provides investors with:
- Accessibility to a variety of investment products
- Tools to help you build and optimize your portfolio
- Flexibility and freedom of managing your investment portfolio
ETF facts as of 10/31/22
Putnam BioRevolution ETF seeks long term capital appreciation.
Strategy and process
- Pursues transformative growth across sectorsThe economic impact of the biology revolution is spreading beyond health care, with potential to transform multiple sectors and drive investment opportunities.
- Collaborative research processA benchmark-agnostic approach leverages unique, integrated insights of Putnam sector analysts and the Sustainable Equity team.
- Concentrated portfolioThe manager seeks outperformance by investing in 30-50 high-conviction stocks selected through disciplined portfolio construction and risk management.
|Fact Sheet (PDF)|
|Summary Prospectus (PDF)|
|Statutory Prospectus (PDF)|
|Statement of Additional Information (SAI) (PDF)|
Total return (%) as of 09/30/22
Cumulative Total return (%) as of 09/30/22
|Cumulative performance||1 yr.||3 yrs.||5 yrs.||Life|
|Net asset value||--||--||--||-1.09%|
Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV, and are not individually redeemed from the fund. Brokerage commissions will reduce returns.
The fund has limited public trading history.
|Net asset value||Market price|
|1 mt. as of 11/30/22||7.31%||7.13%|
|Short-term cap. gain||--|
|Long-term cap. gain||--|
|Number of days at premium||--|
|Number of days at NAV||--|
|Number of days at discount||--|
|Full portfolio holdings||Download XLSX|
Top industry sectors as of 09/30/22
|Cash and net other assets||4.28%|
Sectors will vary over time.